Jane A. Gross, Ph.D.
Board Member
aTYR PHARMA INC (ATYR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jane A. Gross, Ph.D.
Jane A. Gross, Ph.D. is recorded as Board Member at aTYR PHARMA INC (ATYR). aTYR PHARMA INC reported in an 8-K filed May 19, 2023 that Jane A. Gross, Ph.D. was appointed Class II director, effective May 17, 2023.
“The election of two Class II directors, as nominated by the Board, to hold office until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-17–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at aTYR PHARMA INC
Other people whose current roles at this company are on record from its filings.
- Sanjay Shukla CEO, Board Member
- Timothy P. Coughlin Chairman
- Jill Broadfoot CFO
- Nancy E. Denyes General Counsel
- Eric Benevich Board Member
- Jane A. Gross Board Member
- Paul Schimmel Board Member
- Paul Schimmel, Ph.D. Board Member
- Sanjay S. Shukla, M.D., M.S. Board Member
- Sara L. Zaknoen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.